The effect of miR‐30e expression on improving drug sensitivity of PCa cells with or without expression of a functional AR was further supported by our observation on treatments of a chemotherapeutic agent Docetaxel (DTX) in a dose‐dependent manner. The gene discussed is AR; the disease is posterior cortical atrophy.